<?xml version="1.0" encoding="UTF-8"?>
<results title="country">
 <result pre="Introduction A form of pulmonary disease was first reported in" exact="China" post="from a city called Wuhan in the Hubei Province"/>
 <result pre="of genome similarity with SARS-CoV which also previously emerged in" exact="China" post="during 2002–2003 [2]. With the announcement of COVID-19 as"/>
 <result pre="Ebola virus too Phase-III clinical trials are underway in both" exact="China" post="and the USA Favipiravir [favilavir or Avigan] [60, 61]"/>
 <result pre="An antiviral treatment for influenza infection used in Russia and" exact="China" post="(2) Proposed reduction of cytokine storm At present, there"/>
 <result pre="(1) CLQ has been proven effective in treating coronavirus in" exact="China" post="(2) Treating pneumonia patients with SARS-CoV-2 infection Approved for"/>
 <result pre="COVID-19 Pfizer has announced positive clinical trial data performed in" exact="France" post="for this drug along with HCQ Nitazoxanide [58] Materno-Perinatal"/>
 <result pre="with HCQ Nitazoxanide [58] Materno-Perinatal Hospital of the State of" exact="Mexico" post="Pyruvate:ferredoxin oxidoreductase (PFOR) enzyme Inhibits viral protein expression Used"/>
 <result pre="assess tocilizumab’s efficiency Ivermectin [53] (antiparasitic agent) Biomedicine Discovery Institute," exact="Australia" post="HIV-1 integrase protein (IN) and the importin (IMP) α/β1"/>
 <result pre="Phase-II/III trial is being conducted in Italy, Spain, Germany, France," exact="Canada" post="and Russia also Aviptadil [78] (analog of vasoactive intestinal"/>
 <result pre="interim analysis Camrelizumab [AiRuiKa] [80] (monoclonal antibody) South East University," exact="China" post="Programmed cell death 1 (PD-1) Programmed cell death 1"/>
 <result pre="plasminogen activator (tPA) [86] [alteplase] (anti-clotting drug) Researchers at Beth" exact="Israel" post="Deaconess Medical Center (BIDMC) Serine protease It catalyzes the"/>
 <result pre="COVID-19 patients with ARDS Corticosteroids [87] Beijing Chao Yang Hospital," exact="China" post="Cytokines Modulating a variety of cytokines involved in the"/>
 <result pre="C virus NS3 protease inhibitor), Ritonavir and interferon (approved in" exact="China" post="to treat hepatitis C, developed by Ascletis; clinical stage),"/>
 <result pre="patients. This drug is approved for manufacturing and sale in" exact="Japan" post="for the treatment of influenza as an antiviral. In"/>
 <result pre="6). This drug is recommended by the director of the" exact="China" post="National Center for Biotechnology Development under the Ministry of"/>
 <result pre="under the Ministry of Science and Technology to treat COVID-19." exact="Italy" post="has also approved the drug to treat COVID-19 cases."/>
 <result pre="against COVID-19, it is being mass-produced as generic version in" exact="China" post="[45, 46]. Ritonavir and lopinavir (Kaletra) These drugs are"/>
 <result pre="Fig. 6. A combination of these drugs is recommended in" exact="Italy" post="to treat COVID-19 patients. Several trials are going on"/>
 <result pre="or in combination of other drugs. A collaborative research from" exact="China" post="and the UK conducted a clinical trial to examine"/>
 <result pre="the efforts to sequence the genetic material of SARS-CoV-2 by" exact="China" post="throughout the world, (2) coronaviruses were already on the"/>
 <result pre="also exhibited a good safety profile A Phase-III trial in" exact="Saudi Arabia" post="is currently underway AZD1222 (previously called ChAdOx1) [18] Jenner"/>
 <result pre="clinical trial (NCT04276896) Bacillus Calmette–Guérin (BCG) Vaccine [19] Research group," exact="Netherlands" post="Live Attenuated Virus The Research group will recruit 1000"/>
 <result pre="randomized controlled trial in up to 4170 healthcare workers across" exact="Australia" post="Phase-III clinical trial (NCT04327206) Oral bacTRL-Spike [91] Symvivo Corporation"/>
 <result pre="Institute of Virology; Phase-II), BBIBP-CorV (Beijing Institute of Biological Products," exact="China" post="National Pharmaceutical Group (Sinopharm); Phase-I/II), GX-19 (Genexine; Phase-I/II), Sputnik"/>
 <result pre="trial of new drug candidate, SNG001 For SARS-CoV-2 coronavirus initiated." exact="Thailand" post="Medical News. https://www.thailandmedical.news/news/covid-19-drug-research-second-phase-of-clinical-trial-of-new-drug-candidate,-sng001-for-sars-cov-2-coronavirus-initiated. Accessed 11 May 2020 86.BIDMC launches"/>
</results>
